Literature DB >> 23905149

An ocular prosthesis for a geriatric patient: a case report.

Vikas B Kamble1, Mukesh Kumar, Debashis Panigrahi.   

Abstract

When geriatric patients with maxillofacial defects are handled, the clinician must be confident of addressing and managing the psychology of these patients. It is also required that the clinician must understand and be sensitive to the medical and financial states of geriatric patients. The loss of an eye has a far-reaching impact on an individual's psychology and an immediate replacement is necessary to promote the physical and psychological healing of the patient and to improve his/her social acceptance. Special approaches and treatment goals are considered while treating geriatric patients with ocular defects and special consideration is given to the appointment length, the number of appointments and their medical and financial statuses. This article presents the prosthetic rehabilitation of a geriatric patient with an ocular defect, with a customized stock ocular prosthesis, by using a minimal intervention geriatric approach.

Entities:  

Keywords:  Geriatric patient; Ocular prosthesis; Stock ocular prosthesis

Year:  2013        PMID: 23905149      PMCID: PMC3708244          DOI: 10.7860/JCDR/2013/5423.3074

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  4 in total

Review 1.  Ocular prosthesis.

Authors:  Kuldeep Raizada; Deepa Rani
Journal:  Cont Lens Anterior Eye       Date:  2007-02-22       Impact factor: 3.077

2.  Ocular prosthetics: use of a tissue conditioner material to modify a stock ocular prosthesis.

Authors:  R K Ow; S Amrith
Journal:  J Prosthet Dent       Date:  1997-08       Impact factor: 3.426

3.  The fitting and fabrication of a custom resin artificial eye.

Authors:  P Benson
Journal:  J Prosthet Dent       Date:  1977-11       Impact factor: 3.426

4.  Modified stock-eye ocular prosthesis.

Authors:  S Taicher; H M Steinberg; I Tubiana; M Sela
Journal:  J Prosthet Dent       Date:  1985-07       Impact factor: 3.426

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.